NCT00495170View on ClinicalTrials.gov

Concurrent Proton and Chemotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 14, 2006

Primary Completion Date

June 14, 2017

Study Completion Date

June 14, 2017

Conditions

Lung Cancer

Interventions

DRUG

Carboplatin

2 area under curve (AUC) by vein Weekly

RADIATION

Proton Radiotherapy

2 GY/fraction for 37 fractions (daily treatment, Monday to Friday, for 7.5 weeks).

DRUG

Paclitaxel

50 mg/m\^2 by vein Weekly

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors

lead

M.D. Anderson Cancer Center

OTHER

NCT00495170 - Concurrent Proton and Chemotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) | Biotech Hunter | Biotech Hunter